We then conducted a series of studies to explore the mechanisms by which NR4A3 inhibits HCC progression and we found that NR4A3 functions by regulating the transcriptional activity of CDKN2AIP in HCC. Here, NR4A3 is linked to hepatocellular carcinoma.